Schedule M Draft Sets Zero Microbial Growth for Sterile Drugs
Health Ministry proposes Schedule M changes requiring zero microbial growth in Grade A sterile drug areas, aligning Indian GMP rules with WHO TRS 1044.
Health Ministry proposes Schedule M changes requiring zero microbial growth in Grade A sterile drug areas, aligning Indian GMP rules with WHO TRS 1044.
Theon Group has bought Maneesh Pharma’s Unit VI in Baddi, Himachal Pradesh, through a slump sale. Renamed Zoevita Lifesciences, the WHO-GMP oral-solids plant can make 3 billion tablets, 150 million capsules and 30 million sachets a year, with oral liquids planned.